Relation of pre-event use of inhibitors of the renin-angiotensin system with myocardial infarct size in patients presenting with a first ST-segment elevation myocardial infarction

American Journal of Cardiology

Volumn 106, Issue 5, 2010, Pages 646-649

  Shariff, Nasir ^a   Dunbar, Christina ^a   Matsumura, Martin E ^a  

^a LEHIGH VALLEY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TROPONIN I; ANGIOTENSIN 1 RECEPTOR ANTAGONIST;

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HEART INFARCTION SIZE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STROKE; COHORT ANALYSIS; COMPLICATION; ELECTROCARDIOGRAPHY; MIDDLE AGED; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; COHORT STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 77955854976     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.04.017     Document Type: Article

References (14)

1. J. Valles, M.T. Santos, M.P. Fuset, A. Moscardo, M. Ruano, F. Perez, M. Pion, S. Brea, and J. Aznar Partial inhibition of platelet thromboxane A2 synthesis by aspirin is associated with myonecrosis in patients with ST-segment elevation myocardial infarction Am J Cardiol 99 2007 19 25
2. L. Moran, T. Fugate, Y. Xiang, C. Cianci, and M. Matsumura Statin pretreatment is protective despite an association with greater coronary artery disease burden in patients presenting with a first ST-segment elevation myocardial infarction Prev Cardiol 11 2008 21 25
3. The Heart Outcomes Prevention Evaluation Study Investigators Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients N Engl J Med 342 2000 145 153
4. S.K. Charan, S. Arora, S. Goyal, K. Kishore, R. Ray, N.T. Chandra, and A.D. Singh Cardioprotective effects of benazapril, an angiotensin-converting enzyme inhibitor, in an ischemia-reperfusion model of myocardial infarction J Renin Angio Aldo Syst 10 2009 201 209
5. V. Papademetriou Inhibition of the renin-angiotensin-aldosterone system to prevent ischemic and atherothrombotic events Am Heart J 157 Suppl 2009 S24 S30
6. S. Chia, F. Senatore, O.C. Raffel, H. Lee, F.J. Wackers, and I.K. Jang Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction JACC Cardiovasc Interv 1 2008 415 423
7. D. Tzivoni, D. Koukoui, V. Guetta, L. Nocack, and G. Cowing Comparison of troponin T to creatine kinase and to radionuclide cardiac imaging infarct size in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty Am J Cardiol 101 2008 753 757
8. J. Hallen, P. Buser, J. Schwitter, P. Petzelbauer, B. Geudelin, M.W. Fagerland, A.S. Jaffe, and D. Atar Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-segment elevation myocardial infarction Am J Cardiol 104 2009 1472 1477
9. U. Benedetto, G. Melina, F. Capuano, C. Comito, R. Bianchini, C. Simon, S. Refice, E. Angeloni, and R. Sinatra Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgery J Cardiovasc Med 9 2008 1098 1103
10. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 288 2002 2981 2997
11. S. Julius, S.E. Kjeldsen, M. Weber, H.R. Brunner, S. Ekman, L. Hansson, T. Hua, J. Laragh, G.T. McInnes, L. Mitchell, F. Plat, S. Schork, B.Zanchetti Smith VALUE trial group Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomized trial Lancet 363 2004 2022 2031
12. M.H. Strauss, and A.S. Hall Angiotensin receptor blockers may increase the risk of myocardial infarction: unraveling the ARB-MI paradox Circulation 114 2006 838 854
13. S. Rasoul, M.B. Nienhuis, J.P. Ottervanger, R.J. Slingerland, M.J. de Boer, J.H. Dambrink, N.M. Ernst, J.C. Hoorntje, A.T. Gosselink, H. Suryapranata, F. Zijlstra, and A.W. van't Hof Predictors of elevated cardiac troponin T on admission in ST-segment elevation myocardial infarction Ann Clin Biochem 43 2006 281 286
14. S. Kennon, K. Barakat, G.A. Hitman, C.P. Price, P.G. Mills, K. Ranjadayalan, J. Cooper, H. Clark, and A.D. Timmis Angiotensin-converting enzyme inhibition is associated with reduced troponin release in nonST-segment elevation acute coronary syndromes J Am Coll Cardiol 38 2001 724 728